variable. People make these flippant comments that science is not reproducible. These first five papers show there are layers of complexity here that make it hard to say that, says Charles Sawyers, an eLife editor and cancer biologist at Memorial Sloan Kettering Cancer Center in New York City.
Date: Jan 18, 2017
Category: Health
Source: Google
Flatiron, Foundation Med Link Records of 20000 Cancer Patients
What you might consider a clunky manual method is also a very efficient way to ask and answer questions, rather than extracting everything from medical records and analyzing it later, says Charles Sawyers, a leading cancer researcher at Memorial Sloan Kettering who is leading GENIE. Id love a me
Date: Nov 03, 2016
Category: Health
Source: Google
Cancer drug discovered by UCLA sets off takeover fight among biotech companies
Work on the drug began at UCLA in the early 2000s when Charles Sawyers, then a professor of medicine at the university as well as an investigator at the Howard Hughes Medical Institute, identified why prostate cancer may fail to respond to first-generation cancer drugs.
Date: Jul 06, 2016
Category: Business
Source: Google
UCLA will get hundreds of millions for rights to prostate cancer drug
The research on Xtandi was led by chemist Michael Jung, who has been at UCLA since 1974, and Dr. Charles Sawyers, now at the Memorial Sloan Kettering Cancer Center in New York. The two men and six other researchers will share equally in the proceeds from their 37.5% stake in the drug's royalty inter
Date: Mar 04, 2016
Category: Health
Source: Google
Rights To UCLA-Developed Prostate Cancer Drug Sold For $1.14B
Research into the drug began in the early 2000s and was conducted by teams led by Michael Jung, a professor of chemistry and biochemistry, and Dr. Charles Sawyers, a former professor of medicine urology and pharmacology and a researcher at UCLAs Jonsson Comprehensive Cancer Center. Sawyers is now a
Date: Mar 04, 2016
Category: Health
Source: Google
Link found between breast-cancer genes, prostate cancer
Previous studies had turned up such mutations in a small fraction of men with early-stage disease, but we had no idea they were that common in advanced prostate cancer, said Charles Sawyers, chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and one of t
Date: May 22, 2015
Category: Health
Source: Google
Seragon Pharmaceuticals Announces Acquisition Agreement With Genentech
I would also like to thank Dr. Charles Sawyers for his foundational work helping to elucidate the molecular determinants of resistance for hormone dependent prostate cancer. This is an ideal path, which will hopefully translate to improving the lives of patients," said Peter Svennilson, Founder and
Date: Jul 02, 2014
Category: Business
Source: Google
Reality Check on Cancer: Fast Progress But Too Many Preventable Deaths
e are finally seeing the payoff of investments over the past ten to 30 years that built up a body of knowledge about the underpinnings and root causes of cancer, says Dr. Charles Sawyers, president of AACR and chair of human oncology and pathogenesis at Memorial Sloan Kettering Cancer Center.
Date: Sep 17, 2013
Category: Health
Source: Google
Youtube
PI3K Dream Team on 2010 SU2C Show
From the 2010 SU2C show, PI3K Dream Team leaders discuss their approac...
Category:
Nonprofits & Activism
Uploaded:
13 Sep, 2010
Duration:
1m 57s
Ethan Zohn's Dark Days Fighting Cancer
Cancer survivor and "Survivor" winner Ethan Zohn tells Katie Couric ab...
Category:
News & Politics
Uploaded:
08 Sep, 2010
Duration:
3m 18s
AUA 2011 Prostate Cancer News
Sally Church, PhD from Pharma Strategy Blog shares news from AUA 2011,...
Category:
Science & Technology
Uploaded:
16 May, 2011
Duration:
4m 11s
Dr. Sawyers on Outsmarting Cancer
Dr. Charles Sawyers tells Katie Couric about the difficulties in treat...
Category:
News & Politics
Uploaded:
08 Sep, 2010
Duration:
1m 42s
Progress Report: PI3K Dream Team
Stand Up To Cancer PI3K Dream Team scientists explain their progress o...
Category:
Nonprofits & Activism
Uploaded:
08 Sep, 2010
Duration:
2m 10s
Sequencing Cancer Genomes--Targete... Cancer...
Applying DNA sequencing to cancer genomes is providing insights that h...